Found: 47
Select item for more details and to access through your institution.
Efficacy of BRAF‐Inhibitor Therapy in BRAF<sup>V600E</sup>‐Mutated Adult Langerhans Cell Histiocytosis.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1001, doi. 10.1002/onco.13541
- By:
- Publication type:
- Article
Identification of a Novel EHBP1‐MET Fusion in an Intrahepatic Cholangiocarcinoma Responding to Crizotinib.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1005, doi. 10.1634/theoncologist.2020-0535
- By:
- Publication type:
- Article
Nivolumab‐Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1009, doi. 10.1002/onco.13553
- By:
- Publication type:
- Article
A Phase II Single Arm Pilot Study of the CHK1 Inhibitor Prexasertib (LY2606368) in BRCA Wild‐Type, Advanced Triple‐Negative Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1013, doi. 10.1634/theoncologist.2020-0491
- By:
- Publication type:
- Article
Chemoradiation‐Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1015, doi. 10.1634/theoncologist.2019-0759
- By:
- Publication type:
- Article
Real‐World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1023, doi. 10.1634/theoncologist.2019-0891
- By:
- Publication type:
- Article
Capacity to Provide Geriatric Specialty Care for Older Adults in Community Oncology Practices.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1032, doi. 10.1634/theoncologist.2020-0189
- By:
- Publication type:
- Article
Assessing and Addressing the Need for Cancer Patient Education in a Resource‐Limited Setting in Haiti.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1039, doi. 10.1634/theoncologist.2019-0258
- By:
- Publication type:
- Article
Prioritization of Patients with Abnormal Breast Findings in the Alerta Rosa Navigation Program to Reduce Diagnostic Delays.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1047, doi. 10.1634/theoncologist.2020-0228
- By:
- Publication type:
- Article
Burundi Cancer Care Needs: A Call to Action.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1055, doi. 10.1634/theoncologist.2020-0410
- By:
- Publication type:
- Article
Patients' Understanding of Oncology Clinical Endpoints: Environmental Scan and Focus Groups.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1060, doi. 10.1634/theoncologist.2020-0402
- By:
- Publication type:
- Article
EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1067, doi. 10.1002/onco.13554
- By:
- Publication type:
- Article
D‐Dimer Enhances Risk‐Targeted Thromboprophylaxis in Ambulatory Patients with Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1075, doi. 10.1002/onco.13540
- By:
- Publication type:
- Article
A Phase II Prospective, Randomized, Double‐Blind, Placebo‐Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor‐Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1854, doi. 10.1634/theoncologist.2020-0417
- By:
- Publication type:
- Article
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1825, doi. 10.1634/theoncologist.2020-0521
- By:
- Publication type:
- Article
Phase II Multicenter, Open‐Label Study of Oral ENMD‐2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1837, doi. 10.1634/theoncologist.2020-0093
- By:
- Publication type:
- Article
Phase Ib/II Study of Biweekly TAS‐102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1855, doi. 10.1634/theoncologist.2020-0643
- By:
- Publication type:
- Article
Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1864, doi. 10.1634/theoncologist.2020-0681
- By:
- Publication type:
- Article
Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1869, doi. 10.1634/theoncologist.2020-0640
- By:
- Publication type:
- Article
Phase II Trial of Neoadjuvant Bevacizumab with Modified FOLFOX7 in Patients with Stage II and III Rectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1879, doi. 10.1634/theoncologist.2020-0642
- By:
- Publication type:
- Article
Effect of a Structured Teaching Module Including Intensive Prophylactic Measures on Reducing the Incidence of Capecitabine‐Induced Hand‐Foot Syndrome: Results of a Prospective Randomized Phase III Study.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1886, doi. 10.1634/theoncologist.2020-0698
- By:
- Publication type:
- Article
A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1893, doi. 10.1634/theoncologist.2020-0759
- By:
- Publication type:
- Article
Single‐Agent Versus Double‐Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1900, doi. 10.1634/theoncologist.2020-0808
- By:
- Publication type:
- Article
Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I–III HER2‐Positive Breast Cancer: A Phase II Clinical Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1909, doi. 10.1002/onco.13546
- By:
- Publication type:
- Article
Safety and Preliminary Efficacy of Ramucirumab in Combination with FOLFOX4 in Patients with Advanced Hepatocellular Carcinoma: A Nonrandomized, Open‐Label, Phase Ib Study.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1921, doi. 10.1002/onco.13550
- By:
- Publication type:
- Article
Homeopathic Treatment as an Add‐On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non‐Small Cell Lung Cancer: A Prospective, Randomized, Placebo‐Controlled, Double‐Blind, Three‐Arm, Multicenter Study
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1930, doi. 10.1002/onco.13548
- By:
- Publication type:
- Article
Adjuvant Treatment with 5‐Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1956, doi. 10.1634/theoncologist.2020-0225
- By:
- Publication type:
- Article
Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1968, doi. 10.1002/ONCO.13521
- By:
- Publication type:
- Article
High Serum Vitamin B12 Levels Associated with C‐Reactive Protein in Older Patients with Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1980, doi. 10.1634/theoncologist.2019-0894
- By:
- Publication type:
- Article
AR‐V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost‐Saving Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1990, doi. 10.1634/theoncologist.2020-0043
- By:
- Publication type:
- Article
Clinical Impact of Plasma and Tissue Next‐Generation Sequencing in Advanced Non‐Small Cell Lung Cancer: A Real‐World Experience.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1996, doi. 10.1634/theoncologist.2020-0148
- By:
- Publication type:
- Article
The Hospitalist Model and Oncology: Oncologist Opinions About Inpatient Cancer Care Delivery.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2006, doi. 10.1634/theoncologist.2020-0514
- By:
- Publication type:
- Article
Pregnancy in Women with Metastatic Sarcomas.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2010, doi. 10.1002/onco.13529
- By:
- Publication type:
- Article
A Timely Oral Option: Single‐Agent Vinorelbine in Desmoid Tumors.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2013, doi. 10.1002/ONCO.13516
- By:
- Publication type:
- Article
Regarding "The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors".
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2017, doi. 10.1002/ONCO.13517
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2018, doi. 10.1002/ONCO.13518
- By:
- Publication type:
- Article
Regarding Blood‐Based Next‐Generation Sequencing Analysis of Appendiceal Cancers.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2019, doi. 10.1002/onco.13559
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2021, doi. 10.1002/onco.13558
- By:
- Publication type:
- Article
Correlation Between Bevacizumab Exposure and Survival Does Not Necessarily Imply Causality.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2022, doi. 10.1002/onco.13564
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2023, doi. 10.1002/onco.13565
- By:
- Publication type:
- Article
Results of the Survey Conducted Among Caribbean Physicians on a Zoom Meeting Discussing the Article "A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group"
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2024, doi. 10.1002/onco.13556
- By:
- Publication type:
- Article
Reviewer Acknowledgment.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2029, doi. 10.1002/onco.13635
- Publication type:
- Article
Reviewer Acknowledgment.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2032, doi. 10.1002/onco.13635
- Publication type:
- Article
Reviewer Acknowledgment.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2032, doi. 10.1002/onco.13635
- Publication type:
- Article
Reviewer Acknowledgment.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2032, doi. 10.1002/onco.13636
- Publication type:
- Article
Reviewer Acknowledgment.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2032, doi. 10.1002/onco.13635
- Publication type:
- Article
Reviewer Acknowledgment.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e2032, doi. 10.1002/onco.13635
- Publication type:
- Article